INSMED
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is ARIKAYCEยฎ (amikacin liposome inhalation suspension), which is approved in the United States for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. MAC lung disease is a rare and often chroni... c infection that can cause irreversible lung damage and can be fatal. Insmed's earlier-stage clinical pipeline includes INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases, and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for rare pulmonary disorders, including pulmonary arterial hypertension.
INSMED
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1988-01-01
Address:
Bridgewater, New Jersey, United States
Country:
United States
Website Url:
http://www.insmed.com
Total Employee:
501+
Status:
Active
Contact:
+1 732) 997-4600
Email Addresses:
[email protected]
Total Funding:
1.37 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2010-12-02 | Transave | Transave acquired by Insmed | N/A |
2000-05-31 | Celtrix Pharmaceuticals | Celtrix Pharmaceuticals acquired by Insmed | N/A |
Investors List
Forbion Capital Partners
Forbion Capital Partners investment in Post-IPO Equity - Insmed
Key Employee Changes
Date | New article |
---|---|
2022-05-23 | Insmed Names Drayton Wise Chief Commercial Officer |
2020-01-30 | Insmed appoints Bonstein chief financial officer |
Official Site Inspections
http://www.insmed.com Semrush global rank: 2.3 M Semrush visits lastest month: 8.16 K
- Host name: 195.126.196.104.bc.googleusercontent.com
- IP address: 104.196.126.195
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York